HK Stock MarketDetailed Quotes

02561 VISEN PHARMA-B

Watchlist

47.800
+0.200+0.42%

Market Closed Apr 25 16:08 CST

5.45BMarket Cap-27.68P/E (TTM)

VISEN PHARMA-B Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

Operating income

Operating expenses

Gross profit

Administrative expenses

-8.12%-86.43M

-0.50%-64.39M

54.95%-79.94M

---64.06M

-1.78%-177.45M

-1,002.01%-174.35M

---15.82M

Research and development expenses

-56.91%-90.52M

-54.68%-58.91M

67.87%-57.69M

---38.08M

34.54%-179.55M

-320.69%-274.28M

---65.2M

Special items of operating profit

95.41%-5.13M

94.27%-6.07M

-262.60%-111.62M

---105.95M

438.60%68.65M

-43.40%-20.27M

---14.14M

Operating profit

26.95%-182.08M

37.83%-129.37M

13.56%-249.25M

-208.09M

38.51%-288.35M

-392.77%-468.9M

-95.16M

Financing cost

49.21%-161K

47.98%-129K

48.79%-317K

---248K

15.67%-619K

-140.66%-734K

---305K

Adjustment items of earning before tax

----

-331.40%-15.14M

---3.51M

Earning before tax

26.98%-182.24M

37.84%-129.5M

13.63%-249.57M

-208.34M

40.39%-288.97M

-389.82%-484.78M

-98.97M

After-tax profit from continuing operations

26.98%-182.24M

37.84%-129.5M

13.63%-249.57M

-208.34M

40.39%-288.97M

-389.82%-484.78M

-98.97M

Earning after tax

26.98%-182.24M

37.84%-129.5M

13.63%-249.57M

-208.34M

40.39%-288.97M

-389.82%-484.78M

-98.97M

Profit attributable to shareholders

26.98%-182.24M

37.84%-129.5M

13.63%-249.57M

-208.34M

40.39%-288.97M

-389.82%-484.78M

-98.97M

Basic earnings per share

Diluted earnings per share

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unaudited opinion

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020
Operating income
Operating expenses
Gross profit
Administrative expenses	-8.12%-86.43M	-0.50%-64.39M	54.95%-79.94M	---64.06M	-1.78%-177.45M	-1,002.01%-174.35M	---15.82M
Research and development expenses	-56.91%-90.52M	-54.68%-58.91M	67.87%-57.69M	---38.08M	34.54%-179.55M	-320.69%-274.28M	---65.2M
Special items of operating profit	95.41%-5.13M	94.27%-6.07M	-262.60%-111.62M	---105.95M	438.60%68.65M	-43.40%-20.27M	---14.14M
Operating profit	26.95%-182.08M	37.83%-129.37M	13.56%-249.25M	-208.09M	38.51%-288.35M	-392.77%-468.9M	-95.16M
Financing cost	49.21%-161K	47.98%-129K	48.79%-317K	---248K	15.67%-619K	-140.66%-734K	---305K
Adjustment items of earning before tax	----	----	----	----	----	-331.40%-15.14M	---3.51M
Earning before tax	26.98%-182.24M	37.84%-129.5M	13.63%-249.57M	-208.34M	40.39%-288.97M	-389.82%-484.78M	-98.97M
After-tax profit from continuing operations	26.98%-182.24M	37.84%-129.5M	13.63%-249.57M	-208.34M	40.39%-288.97M	-389.82%-484.78M	-98.97M
Earning after tax	26.98%-182.24M	37.84%-129.5M	13.63%-249.57M	-208.34M	40.39%-288.97M	-389.82%-484.78M	-98.97M
Profit attributable to shareholders	26.98%-182.24M	37.84%-129.5M	13.63%-249.57M	-208.34M	40.39%-288.97M	-389.82%-484.78M	-98.97M
Basic earnings per share
Diluted earnings per share
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	Unaudited opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion
Auditor	Ernst & Young	--	Ernst & Young	--	Ernst & Young	Ernst & Young	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.